syndrome	score	normalized_score
CLUSTER HEADACHE, FAMILIAL	1.111111	100.0
PORPHYRIA, ACUTE HEPATIC	1.0	90.0000090000009
CHIARI MALFORMATION TYPE II	1.0	90.0000090000009
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.5	45.00000450000045
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.5	45.00000450000045
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.33789921	30.410931941093196
Contractural arachnodactyly, congenital	0.33789921	30.410931941093196
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.33519174	30.167259616725968
PARAGANGLIOMAS 3	0.333333	29.999972999997297
PARAGANGLIOMAS 4	0.333333	29.999972999997297
PARAGANGLIOMAS 1	0.333333	29.999972999997297
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.22670239999999997	20.403218040321804
SANDHOFF DISEASE	0.2	18.00000180000018
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.2	18.00000180000018
HYPERLIPOPROTEINEMIA, TYPE I	0.2	18.00000180000018
TIGLIC ACIDEMIA	0.2	18.00000180000018
ANGIOEDEMA, HEREDITARY, TYPE III	0.2	18.00000180000018
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	17.499988749998877
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	17.499988749998877
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	17.499988749998877
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	17.499988749998877
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	17.499988749998877
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	17.499988749998877
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	17.499988749998877
WILLIAMS-BEUREN SYNDROME; WBS	0.11822496000000002	10.64024746402475
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.11559140000000001	10.403227040322706
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.11296973999999999	10.16727761672776
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.11153002000000002	10.037702803770282
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.11111099999999999	9.999990999999099
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.11111099999999999	9.999990999999099
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	9.999990999999099
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.11111099999999999	9.999990999999099
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.11111099999999999	9.999990999999099
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.11111099999999999	9.999990999999099
BUERGER DISEASE	0.11111099999999999	9.999990999999099
#615040 EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1	0.11111099999999999	9.999990999999099
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.09871790000000001	8.88461188846119
TURNPENNY-FRY SYNDROME; TPFS	0.09871790000000001	8.88461188846119
CURRY-JONES SYNDROME	0.09482760000000001	8.534484853448488
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.09338876000000002	8.404989240498924
ANAL SPHINCTER DYSPLASIA; ASDP	0.09153002000000002	8.237702623770264
300270 ADRENOMYODYSTROPHY	0.09153002000000002	8.237702623770264
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.08333330000000001	7.4999977499997765
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.08333330000000001	7.4999977499997765
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08333330000000001	7.4999977499997765
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08333330000000001	7.4999977499997765
CURRARINO SYNDROME	0.08333330000000001	7.4999977499997765
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.08333330000000001	7.4999977499997765
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.08333330000000001	7.4999977499997765
CYCLIC VOMITING SYNDROME	0.0676427	6.087843608784361
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.06435847	5.792262879226288
DESANTO-SHINAWI SYNDROME	0.05590185	5.031167003116701
PRADER-WILLI SYNDROME; PWS	0.05549001	4.99410139941014
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.053997199999999995	4.8597484859748485
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.053997199999999995	4.8597484859748485
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0530914	4.778226477822647
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.049440239999999996	4.449622044962204
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.04932916	4.439624843962484
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0485046	4.365414436541444
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.04829796	4.346816834681683
DIGEORGE SYNDROME; DGS	0.046479999999999994	4.183200418320041
BARDET-BIEDL SYNDROME 1; BBS1	0.04529717	4.07674570767457
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0417391	3.756519375651938
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.0417391	3.756519375651938
Polyarteritis nodosa, childhood-onset	0.0417391	3.756519375651938
HYPER-IGD SYNDROME	0.0417391	3.756519375651938
SCLEROSTEOSIS 1; SOST1	0.041210720000000006	3.708965170896518
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.040943099999999996	3.6848793684879366
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.040101239999999996	3.609111960911196
LEGIUS SYNDROME	0.038076639999999995	3.426897942689794
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.037936849999999994	3.414316841431684
CHROMOSOME 1P36 DELETION SYNDROME	0.03742631	3.3683682368368237
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.03682431	3.314188231418823
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.03646871	3.2821842282184233
TUBEROUS SCLEROSIS	0.0362179	3.2596113259611323
TUBEROUS SCLEROSIS 2; TSC2	0.0362179	3.2596113259611323
SCHAAF-YANG SYNDROME; SHFYNG	0.03587219	3.2284974228497423
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.03536168	3.1825515182551523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.034944920000000004	3.1450431145043116
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.034944920000000004	3.1450431145043116
TEMPLE SYNDROME	0.034678780000000006	3.121090512109052
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.03337064	3.00335790033579
COFFIN-SIRIS SYNDROME 6; CSS6	0.03324505999999999	2.9920556992055696
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.03232053	2.908847990884799
PEROXISOME BIOGENESIS DISORDER 14B	0.0322581	2.9032292903229293
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.0322581	2.9032292903229293
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.0322581	2.9032292903229293
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0322581	2.9032292903229293
PHACE ASSOCIATION	0.0322581	2.9032292903229293
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.0322581	2.9032292903229293
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.0322581	2.9032292903229293
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.0322581	2.9032292903229293
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0322581	2.9032292903229293
EPISODIC ATAXIA, TYPE 6	0.0322581	2.9032292903229293
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.0322581	2.9032292903229293
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.0322581	2.9032292903229293
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.0322581	2.9032292903229293
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.0322581	2.9032292903229293
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0322581	2.9032292903229293
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.0322581	2.9032292903229293
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.0322581	2.9032292903229293
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.0322581	2.9032292903229293
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.0322581	2.9032292903229293
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0322581	2.9032292903229293
STORMORKEN SYNDROME; STRMK	0.0322581	2.9032292903229293
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0322581	2.9032292903229293
EPISODIC ATAXIA, TYPE 2	0.0322581	2.9032292903229293
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.0322581	2.9032292903229293
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.03214364	2.892927889292789
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.031054619999999998	2.7949160794916077
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.031054619999999998	2.7949160794916077
MARFAN SYNDROME; MFS	0.030635710000000003	2.7572141757214177
CORNELIA DE LANGE SYNDROME 1	0.03046179	2.741561374156137
CORNELIA DE LANGE SYNDROME 3	0.03046179	2.741561374156137
ALAGILLE SYNDROME 1; ALGS1	0.03016523	2.7148709714870973
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.029935820000000002	2.6942240694224076
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.029935820000000002	2.6942240694224076
LICHTENSTEIN SYNDROME	0.02974536	2.677082667708267
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.02961466	2.6653196665319667
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.029236659999999998	2.6312996631299663
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.029236659999999998	2.6312996631299663
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.028976480000000002	2.6078834607883463
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.02873764	2.5863878586387856
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.02873764	2.5863878586387856
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.02860492	2.574443057444306
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.02860492	2.574443057444306
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.02860492	2.574443057444306
WITTEVEEN-KOLK SYNDROME	0.028553679999999998	2.5698314569831457
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.02849586	2.564627656462766
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.02819672	2.5377050537705057
GITELMAN SYNDROME	0.02819672	2.5377050537705057
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.02819672	2.5377050537705057
PORPHYRIA VARIEGATA	0.02819672	2.5377050537705057
CHROMOSOME 19p13.13 DELETION SYNDROME	0.02819672	2.5377050537705057
VISCERAL MYOPATHY; VSCM	0.02819672	2.5377050537705057
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.02819672	2.5377050537705057
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.02819672	2.5377050537705057
SHPRINTZEN OMPHALOCELE SYNDROME	0.02759006	2.483105648310565
ZIMMERMANN-LABAND SYNDROME 1	0.02755481	2.479933147993315
ERYTHERMALGIA, PRIMARY	0.027064619999999998	2.4358160435816045
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.026878899999999997	2.4191012419101243
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.026504820000000002	2.385434038543404
CRANIOSYNOSTOSIS 2	0.026305310000000002	2.367478136747814
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.02622838	2.360554436055444
ACHALASIA-MICROCEPHALY SYNDROME	0.0262002	2.358018235801824
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0262002	2.358018235801824
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.026115969999999995	2.350437535043753
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.026069500000000002	2.3462552346255237
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.025895579999999998	2.330602433060243
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.025895579999999998	2.330602433060243
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.0258096	2.3228642322864235
ENDOCARDIAL FIBROELASTOSIS	0.02562466	2.306219630621963
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.02559902	2.303912030391203
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.02559902	2.303912030391203
JABERI-ELAHI SYNDROME; JABELS	0.025593550000000003	2.3034197303419734
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.02544006	2.289605628960563
COSTELLO SYNDROME; CSTLO	0.02517392	2.2656530265653023
GAUCHER DISEASE, PERINATAL LETHAL	0.02517392	2.2656530265653023
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.02497441	2.2476971247697124
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.02484734	2.236260823626082
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.024847339999999996	2.2362608236260817
MOWAT-WILSON SYNDROME; MOWS	0.024761359999999996	2.228522622852262
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.02471664	2.2244978224497824
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.02456621	2.2109591210959123
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.02454531	2.2090781209078125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.024369639999999998	2.193267819326782
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.024073269999999997	2.1665945166594516
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.024073269999999997	2.1665945166594516
#154780 MARSHALL SYNDROME; MRSHS	0.02403783	2.163404916340492
IMMUNODEFICIENCY 61; IMD61	0.02378796	2.1409166140916613
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.023597840000000002	2.1238058123805814
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.02358132	2.1223190122319013
KAGAMI-OGATA SYNDROME	0.023315179999999998	2.0983664098366406
ATELOSTEOGENESIS, TYPE I; AO1	0.023315179999999998	2.0983664098366406
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.02310926	2.079833607983361
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.02310926	2.079833607983361
HOLOPROSENCEPHALY 5; HPE5	0.02301678	2.071510407151041
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.02301678	2.071510407151041
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.022988599999999998	2.0689742068974204
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.022988599999999998	2.0689742068974204
ALAZAMI-YUAN SYNDROME	0.022988599999999998	2.0689742068974204
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.022988599999999998	2.0689742068974204
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.022988599999999998	2.0689742068974204
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.022988599999999998	2.0689742068974204
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.022988599999999998	2.0689742068974204
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.022988599999999998	2.0689742068974204
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.022988599999999998	2.0689742068974204
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.022988599999999998	2.0689742068974204
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.022988599999999998	2.0689742068974204
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.02290698	2.0616284061628405
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.02290262	2.0612360061236004
KABUKI SYNDROME 1	0.0228579	2.0572112057211207
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.02285779	2.0572013057201306
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.02269204	2.04228380422838
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.02269204	2.04228380422838
NEUROFIBROMATOSIS, TYPE I	0.02269204	2.04228380422838
CHROMOSOME 10Q26 DELETION SYNDROME	0.02269204	2.04228380422838
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.02269204	2.04228380422838
YUNIS-VARON SYNDROME	0.02226694	2.00402480040248
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.02226694	2.00402480040248
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.02226694	2.00402480040248
KNIEST-LIKE DYSPLASIA, LETHAL	0.02226694	2.00402480040248
Diamond-Blackfan anemia 1	0.02226694	2.00402480040248
RESTRICTIVE DERMOPATHY, LETHAL	0.02226694	2.00402480040248
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.02226694	2.00402480040248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.02217909	1.99611829961183
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.02217909	1.99611829961183
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.02214136	1.99272259927226
CHROMOSOME 3q13.31 DELETION SYNDROME	0.02180955	1.9628596962859697
KLEEFSTRA SYNDROME	0.0217564	1.9580761958076196
MARSILI SYNDROME; MARSIS	0.0217391	1.9565191956519197
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0217391	1.9565191956519197
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.0217391	1.9565191956519197
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0217391	1.9565191956519197
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.0217391	1.9565191956519197
BRUNNER SYNDROME; BRNRS	0.0217391	1.9565191956519197
CAMURATI-ENGELMANN DISEASE	0.0217391	1.9565191956519197
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.0217391	1.9565191956519197
PARIETAL FORAMINA	0.0217391	1.9565191956519197
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0217391	1.9565191956519197
CHIARI MALFORMATION TYPE I	0.0217391	1.9565191956519197
PAPILLOMA OF CHOROID PLEXUS	0.0217391	1.9565191956519197
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0217391	1.9565191956519197
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.0217391	1.9565191956519197
EPISODIC ATAXIA, TYPE 1; EA1	0.0217391	1.9565191956519197
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0217391	1.9565191956519197
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.0217391	1.9565191956519197
SNEDDON SYNDROME	0.0217391	1.9565191956519197
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.0217391	1.9565191956519197
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.0217391	1.9565191956519197
EPISODIC ATAXIA, TYPE 3	0.0217391	1.9565191956519197
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.0217391	1.9565191956519197
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0217391	1.9565191956519197
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0217391	1.9565191956519197
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.0217391	1.9565191956519197
GLUTAMATE MONOSODIUM SENSITIVITY	0.0217391	1.9565191956519197
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.0217391	1.9565191956519197
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.0217391	1.9565191956519197
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.0217391	1.9565191956519197
NEUROFIBROMATOSIS, TYPE II	0.0217391	1.9565191956519197
#613882 HYPOMAGNESEMIA 6, RENAL; HOMG6	0.0217391	1.9565191956519197
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0217391	1.9565191956519197
WIEDEMANN-STEINER SYNDROME; WDSTS	0.021549759999999998	1.9394785939478594
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.021462659999999998	1.9316395931639592
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.021462659999999998	1.9316395931639592
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.02137843	1.9240588924058895
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0213658	1.9229221922922195
ANGELMAN SYNDROME	0.021166289999999997	1.9049662904966287
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.02113085	1.901776690177669
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0208333	1.8749971874997187
BLOOM SYNDROME	0.0208333	1.8749971874997187
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0208333	1.8749971874997187
VELOCARDIOFACIAL SYNDROME	0.0208333	1.8749971874997187
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.0208333	1.8749971874997187
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0208333	1.8749971874997187
MICROPHTHALMIA, SYNDROMIC 3	0.0208333	1.8749971874997187
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.0208333	1.8749971874997187
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0208333	1.8749971874997187
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0208333	1.8749971874997187
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.0208333	1.8749971874997187
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.0208333	1.8749971874997187
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0208333	1.8749971874997187
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	1.8749971874997187
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0208333	1.8749971874997187
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0208333	1.8749971874997187
MUCOLIPIDOSIS III ALPHA/BETA	0.0208333	1.8749971874997187
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.0208333	1.8749971874997187
FEINGOLD SYNDROME 1; FGLDS1	0.0208333	1.8749971874997187
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.0208333	1.8749971874997187
LISSENCEPHALY, X-LINKED, 2	0.0208333	1.8749971874997187
MUSICAL PERFECT PITCH	0.0208333	1.8749971874997187
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.0208333	1.8749971874997187
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0208333	1.8749971874997187
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.0208333	1.8749971874997187
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.020826229999999998	1.8743608874360889
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020408199999999998	1.8367381836738181
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.020408199999999998	1.8367381836738181
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	1.8367381836738181
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.020408199999999998	1.8367381836738181
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.020408199999999998	1.8367381836738181
INFANTILE SIALIC ACID STORAGE DISEASE	0.020408199999999998	1.8367381836738181
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.8367381836738181
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.8367381836738181
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.8367381836738181
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.020408199999999998	1.8367381836738181
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.8367381836738181
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.8367381836738181
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.8367381836738181
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.8367381836738181
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	1.8367381836738181
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.8367381836738181
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.020408199999999998	1.8367381836738181
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	1.8367381836738181
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.8367381836738181
NEMALINE MYOPATHY 10	0.020408199999999998	1.8367381836738181
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.020408199999999998	1.8367381836738181
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.8367381836738181
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.020408199999999998	1.8367381836738181
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.8367381836738181
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	1.8367381836738181
TYSHCHENKO SYNDROME	0.020408199999999998	1.8367381836738181
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	1.8367381836738181
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	1.8367381836738181
ROIFMAN SYNDROME; RFMN	0.020408199999999998	1.8367381836738181
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.020109799999999997	1.809882180988218
MCDONOUGH SYNDROME	0.020109799999999997	1.809882180988218
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.02	1.8000001800000183
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.02	1.8000001800000183
TREHALASE DEFICIENCY	0.02	1.8000001800000183
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.02	1.8000001800000183
SITOSTEROLEMIA	0.02	1.8000001800000183
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.02	1.8000001800000183
PEUTZ-JEGHERS SYNDROME	0.02	1.8000001800000183
INFLAMMATORY BOWEL DISEASE 11	0.02	1.8000001800000183
HEMOCHROMATOSIS, TYPE 1	0.02	1.8000001800000183
#614616 DIARRHEA 6; DIAR6	0.02	1.8000001800000183
INFUNDIBULOPELVIC DYSGENESIS	0.02	1.8000001800000183
#174900 JUVENILE POLYPOSIS SYNDROME; JPS;;POLYPOSIS, JUVENILE INTESTINAL; PJI;;JUVENILE INTESTINAL POLYPOSIS; JIP;;POLYPOSIS, FAMILIAL, OF ENTIRE GASTROINTESTINAL TRACTJUVENILE POLYPOSIS OF STOMACH, INCLUDED;;JUVENILE POLYPOSIS COLI, INCLUDED	0.02	1.8000001800000183
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.02	1.8000001800000183
OVARIAN HYPERSTIMULATION SYNDROME	0.02	1.8000001800000183
#609812 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;MODY8;;DIABETES AND PANCREATIC EXOCRINE DYSFUNCTION; DPED;;DIABETES-PANCREATIC EXOCRINE DYSFUNCTION SYNDROME	0.02	1.8000001800000183
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.02	1.8000001800000183
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.02	1.8000001800000183
PANCREATITIS, HEREDITARY	0.02	1.8000001800000183
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	1.8000001800000183
Yao syndrome	0.02	1.8000001800000183
SICKLE CELL ANEMIA	0.02	1.8000001800000183
Fabry disease	0.02	1.8000001800000183
#266600 INFLAMMATORY BOWEL DISEASE 1; IBD1REGIONAL ENTERITIS, INCLUDED;;CROHN DISEASE, INCLUDED;;ULCERATIVE COLITIS, INCLUDED;;CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED	0.02	1.8000001800000183
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.02	1.8000001800000183
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.02	1.8000001800000183
LACTOSE INTOLERANCE, ADULT TYPE	0.02	1.8000001800000183
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.02	1.8000001800000183
TROPICAL CALCIFIC PANCREATITIS	0.02	1.8000001800000183
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.02	1.8000001800000183
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.02	1.8000001800000183
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.02	1.8000001800000183
CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENTOF DIAPHRAGM	0.02	1.8000001800000183
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.02	1.8000001800000183
FAMILIAL MEDITERRANEAN FEVER; FMF	0.02	1.8000001800000183
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0199791	1.7981191798119178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.01992584	1.793325779332578
MENTAL RETARDATION, X-LINKED 97; MRX97	0.019897659999999998	1.7907895790789576
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.019897659999999998	1.7907895790789576
POLYCYSTIC OVARY SYNDROME 1	0.019897659999999998	1.7907895790789576
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.019897659999999998	1.7907895790789576
LUSCAN-LUMISH SYNDROME; LLS	0.019897659999999998	1.7907895790789576
CHROMOSOME 16p13.3 DELETION SYNDROME	0.01972633	1.7753698775369877
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.019691019999999997	1.7721919772191976
SMITH-MAGENIS SYNDROME; SMS	0.019691019999999997	1.7721919772191976
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.01956032	1.7604289760428975
LOWE OCULOCEREBRORENAL SYNDROME	0.01956032	1.7604289760428975
XIA-GIBBS SYNDROME	0.01947162	1.7524459752445976
MOEBIUS SYNDROME; MBS	0.01947162	1.7524459752445976
JOUBERT SYNDROME 2	0.01947162	1.7524459752445976
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.01947162	1.7524459752445976
HYPEREKPLEXIA 2; HKPX2	0.01927211	1.7344900734490072
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.01927211	1.7344900734490072
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.01927211	1.7344900734490072
HAREL-YOON SYNDROME; HAYOS	0.01927211	1.7344900734490072
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.01927211	1.7344900734490072
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01927211	1.7344900734490072
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.01896749	1.7070742707074271
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.6981111698111169
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.6981111698111169
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.6981111698111169
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.6981111698111169
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.6981111698111169
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.6981111698111169
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.6981111698111169
JUMPING FRENCHMAN OF MAINE	0.0188679	1.6981111698111169
THUMBS, CONGENITAL CLASPED	0.0188679	1.6981111698111169
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.6981111698111169
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.6981111698111169
ALCOHOL DEPENDENCE	0.0188679	1.6981111698111169
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.6981111698111169
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.6981111698111169
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.6981111698111169
PALMOMENTAL REFLEX	0.0188679	1.6981111698111169
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.6981111698111169
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.6981111698111169
MYOPATHY, CONGENITAL	0.0188679	1.6981111698111169
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.6981111698111169
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.6981111698111169
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.6981111698111169
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.6981111698111169
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.6981111698111169
269800 SENILE PLAQUE FORMATION	0.0188679	1.6981111698111169
DIASTEMATOMYELIA	0.0188679	1.6981111698111169
CERVICAL RIB	0.0188679	1.6981111698111169
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.6981111698111169
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.6981111698111169
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.6981111698111169
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.6981111698111169
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.6981111698111169
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.6981111698111169
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.6981111698111169
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.6981111698111169
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.6981111698111169
RHEUMATOID ARTHRITIS	0.0188679	1.6981111698111169
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.6981111698111169
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.6981111698111169
MOTION SICKNESS	0.0188679	1.6981111698111169
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.6981111698111169
CARDIAC ARRHYTHMIA	0.0188679	1.6981111698111169
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.6981111698111169
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.6981111698111169
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.6981111698111169
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	1.6981111698111169
TRANSSEXUALITY	0.0188679	1.6981111698111169
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.6981111698111169
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.6981111698111169
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.6981111698111169
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.6981111698111169
STICKLER SYNDROME, TYPE II	0.018836790000000003	1.6953112695311274
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.01829158	1.6462423646242366
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.01829158	1.6462423646242366
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.01825106	1.6425955642595567
EPILEPSY-TELANGIECTASIA	0.01825106	1.6425955642595567
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.01825106	1.6425955642595567
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.017919249999999998	1.612732661273266
BOHRING-OPITZ SYNDROME	0.017919249999999998	1.612732661273266
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.01778855	1.600969660096966
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.01778855	1.600969660096966
PALLISTER-KILLIAN SYNDROME	0.01773529	1.596176259617626
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.017612879999999997	1.5851593585159356
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.017612879999999997	1.5851593585159356
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.017612879999999997	1.5851593585159356
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.017612879999999997	1.5851593585159356
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.017612879999999997	1.5851593585159356
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01752865	1.5775786577578659
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.01724334	1.5519007551900756
CHROMOSOME 15q25 DELETION SYNDROME	0.01724334	1.5519007551900756
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01724334	1.5519007551900756
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.01724334	1.5519007551900756
Aarskog-Scott syndrome	0.01724334	1.5519007551900756
SHUKLA-VERNON SYNDROME; SHUVER	0.01724334	1.5519007551900756
Muenke syndrome	0.01724334	1.5519007551900756
ADIPOSIS DOLOROSA	0.01660008	1.4940073494007349
PACHYGYRIA, FRONTOTEMPORAL	0.01656464	1.4908177490817747
CRANIOLENTICULOSUTURAL DYSPLASIA	0.01656464	1.4908177490817747
OROFACIODIGITAL SYNDROME VI	0.01656464	1.4908177490817747
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.01656464	1.4908177490817747
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.01626002	1.4634019463401946
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.01626002	1.4634019463401946
FONTAINE PROGEROID SYNDROME; FPS	0.01626002	1.4634019463401946
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.01626002	1.4634019463401946
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01626002	1.4634019463401946
AL KAISSI SYNDROME; ALKAS	0.01626002	1.4634019463401946
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.01626002	1.4634019463401946
CRANIOFACIOFRONTODIGITAL SYNDROME	0.016129320000000003	1.4516389451638947
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.016129320000000003	1.4516389451638947
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.016129320000000003	1.4516389451638947
GAPO SYNDROME; GAPOS	0.016129320000000003	1.4516389451638947
NOONAN SYNDROME 7; NS7	0.016129320000000003	1.4516389451638947
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.015929810000000003	1.4336830433683045
BRITTLE CORNEA SYNDROME 2; BCS2	0.015929810000000003	1.4336830433683045
COHEN SYNDROME	0.015929810000000003	1.4336830433683045
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.015929810000000003	1.4336830433683045
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.015929810000000003	1.4336830433683045
DESBUQUOIS DYSPLASIA 1	0.01587655	1.4288896428889644
WHITE-SUTTON SYNDROME; WHSUS	0.01566991	1.410292041029204
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.0153846	1.384614138461414
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0153846	1.384614138461414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.0153846	1.384614138461414
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.0153846	1.384614138461414
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.0153846	1.384614138461414
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0153846	1.384614138461414
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.0153846	1.384614138461414
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.0153846	1.384614138461414
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.0153846	1.384614138461414
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0153846	1.384614138461414
#137580 GILLES DE LA TOURETTE SYNDROME; GTS;;TOURETTE SYNDROME; TS;;TOURETTE DISORDERCHRONIC MOTOR TICS, INCLUDED	0.0153846	1.384614138461414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0153846	1.384614138461414
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.0153846	1.384614138461414
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0153846	1.384614138461414
LANDAU-KLEFFNER SYNDROME	0.0153846	1.384614138461414
Adrenoleukodystrophy	0.0153846	1.384614138461414
PHENYLKETONURIA	0.0153846	1.384614138461414
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.0153846	1.384614138461414
SPINOCEREBELLAR ATAXIA 14	0.0153846	1.384614138461414
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.0153846	1.384614138461414
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0153846	1.384614138461414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.0153846	1.384614138461414
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0153846	1.384614138461414
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.0153846	1.384614138461414
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0153846	1.384614138461414
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0153846	1.384614138461414
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0153846	1.384614138461414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0153846	1.384614138461414
MENTAL RETARDATION, X-LINKED 91; MRX91	0.01516012	1.3644109364410937
UROFACIAL SYNDROME	0.014953479999999998	1.3458133345813335
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.014953479999999998	1.3458133345813335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.014953479999999998	1.3458133345813335
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.0147059	1.3235311323531131
DUANE RETRACTION SYNDROME 1	0.0147059	1.3235311323531131
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.0147059	1.3235311323531131
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0147059	1.3235311323531131
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0147059	1.3235311323531131
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.0147059	1.3235311323531131
CHROMOSOME 5Q12 DELETION SYNDROME	0.0147059	1.3235311323531131
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.0147059	1.3235311323531131
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0147059	1.3235311323531131
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.0147059	1.3235311323531131
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0147059	1.3235311323531131
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.0147059	1.3235311323531131
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0147059	1.3235311323531131
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.0147059	1.3235311323531131
GAUCHER DISEASE, TYPE II	0.0147059	1.3235311323531131
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0147059	1.3235311323531131
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0147059	1.3235311323531131
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0147059	1.3235311323531131
#221900 PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR;;RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC; NCRNA;;RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT;;PERSISTENT FETAL VASCULATURE	0.0147059	1.3235311323531131
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	0.0147059	1.3235311323531131
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.0147059	1.3235311323531131
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.0147059	1.3235311323531131
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0147059	1.3235311323531131
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.0147059	1.3235311323531131
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0147059	1.3235311323531131
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0147059	1.3235311323531131
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0147059	1.3235311323531131
ADAMS-OLIVER SYNDROME 1; AOS1	0.0147059	1.3235311323531131
DESBUQUOIS DYSPLASIA 2; DBQD2	0.014401279999999999	1.296115329611533
HURLER SYNDROME	0.014401279999999999	1.296115329611533
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.014401279999999999	1.296115329611533
MARSHALL-SMITH SYNDROME; MRSHSS	0.014401279999999999	1.296115329611533
COFFIN-SIRIS SYNDROME 3; CSS3	0.014401279999999999	1.296115329611533
HURLER-SCHEIE SYNDROME	0.014401279999999999	1.296115329611533
COFFIN-SIRIS SYNDROME 4; CSS4	0.014401279999999999	1.296115329611533
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.014401279999999999	1.296115329611533
TRANSALDOLASE DEFICIENCY	0.014401279999999999	1.296115329611533
BARATELA-SCOTT SYNDROME	0.014401279999999999	1.296115329611533
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.014270580000000001	1.2843523284352332
ZTTK SYNDROME; ZTTKS	0.014270580000000001	1.2843523284352332
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.014270580000000001	1.2843523284352332
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.01422995	1.2806956280695627
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.013353039999999998	1.201773720177372
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.013353039999999998	1.201773720177372
Temtamy preaxial brachydactyly syndrome	0.013353039999999998	1.201773720177372
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.013353039999999998	1.201773720177372
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.013353039999999998	1.201773720177372
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.013353039999999998	1.201773720177372
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.013353039999999998	1.201773720177372
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.013353039999999998	1.201773720177372
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.013353039999999998	1.201773720177372
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.013353039999999998	1.201773720177372
IMMUNODEFICIENCY 49; IMD49	0.013353039999999998	1.201773720177372
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.013353039999999998	1.201773720177372
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.013353039999999998	1.201773720177372
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.013353039999999998	1.201773720177372
BENT BONE DYSPLASIA SYNDROME; BBDS	0.013353039999999998	1.201773720177372
ELSAHY-WATERS SYNDROME; ESWS	0.013353039999999998	1.201773720177372
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.013353039999999998	1.201773720177372
WAARDENBURG SYNDROME, TYPE 1; WS1	0.013353039999999998	1.201773720177372
FRONTOMETAPHYSEAL DYSPLASIA	0.013353039999999998	1.201773720177372
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.01322234	1.190010719001072
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.01322234	1.190010719001072
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.01322234	1.190010719001072
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.01322234	1.190010719001072
LATERAL MENINGOCELE SYNDROME	0.01322234	1.190010719001072
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.01322234	1.190010719001072
#278250 WRINKLY SKIN SYNDROME; WSS	0.01322234	1.190010719001072
3MC SYNDROME 2	0.01322234	1.190010719001072
MEESTER-LOEYS SYNDROME; MRLS	0.01322234	1.190010719001072
LOEYS-DIETZ SYNDROME 5	0.01322234	1.190010719001072
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.01322234	1.190010719001072
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.01318171	1.1863540186354018
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.01316908	1.1852173185217318
#614976 CARPENTER SYNDROME 2; CRPT2	0.01316908	1.1852173185217318
BARDET-BIEDL SYNDROME 21; BBS21	0.01296957	1.1672614167261417
RETINAL DYSTROPHY AND OBESITY; RDOB	0.01296957	1.1672614167261417
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.01296957	1.1672614167261417
MEHMO SYNDROME; MEHMO	0.01296957	1.1672614167261417
COFFIN-SIRIS SYNDROME 7; CSS7	0.012962439999999999	1.1666197166619716
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.012962439999999999	1.1666197166619716
EMANUEL SYNDROME	0.012762929999999999	1.1486638148663815
PITT-HOPKINS SYNDROME	0.012762929999999999	1.1486638148663815
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.01152248	1.0370233037023304
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.01152248	1.0370233037023304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.01152248	1.0370233037023304
ROIFMAN-CHITAYAT SYNDROME	0.01152248	1.0370233037023304
NOONAN SYNDROME 5; NS5	0.01152248	1.0370233037023304
#170100 PROLIDASE DEFICIENCY	0.01152248	1.0370233037023304
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.01152248	1.0370233037023304
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.01152248	1.0370233037023304
HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	0.011494299999999999	1.0344871034487102
MENTAL RETARDATION, X-LINKED 73	0.011494299999999999	1.0344871034487102
HOLOPROSENCEPHALY 11	0.011494299999999999	1.0344871034487102
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.011494299999999999	1.0344871034487102
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.011494299999999999	1.0344871034487102
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.011494299999999999	1.0344871034487102
GOLDBERG-SHPRINTZEN SYNDROME	0.011494299999999999	1.0344871034487102
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.011494299999999999	1.0344871034487102
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.011494299999999999	1.0344871034487102
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.011494299999999999	1.0344871034487102
Lipodystrophy, congenital generalized, type 2	0.011494299999999999	1.0344871034487102
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.011494299999999999	1.0344871034487102
EVEN-PLUS SYNDROME	0.011494299999999999	1.0344871034487102
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.011494299999999999	1.0344871034487102
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.011494299999999999	1.0344871034487102
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.011494299999999999	1.0344871034487102
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.011494299999999999	1.0344871034487102
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.011494299999999999	1.0344871034487102
#307150 HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2;;CHROMOSOME Xq27.1 INTERCHROMOSOMAL INSERTION SYNDROME;;CGH;;HCG	0.011494299999999999	1.0344871034487102
9q subtelomeric deletion syndrome	0.011494299999999999	1.0344871034487102
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.011494299999999999	1.0344871034487102
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.011494299999999999	1.0344871034487102
CARNEY COMPLEX, TYPE 1; CNC1	0.011494299999999999	1.0344871034487102
46,XY SEX REVERSAL 6; SRXY6	0.011494299999999999	1.0344871034487102
CRANIORHINY	0.011494299999999999	1.0344871034487102
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.011494299999999999	1.0344871034487102
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.011494299999999999	1.0344871034487102
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.011494299999999999	1.0344871034487102
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.011494299999999999	1.0344871034487102
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.011494299999999999	1.0344871034487102
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.011494299999999999	1.0344871034487102
PRIMROSE SYNDROME; PRIMS	0.011494299999999999	1.0344871034487102
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.011494299999999999	1.0344871034487102
OVARIAN DYSGENESIS 2; ODG2	0.011494299999999999	1.0344871034487102
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.011494299999999999	1.0344871034487102
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.011494299999999999	1.0344871034487102
Lipodystrophy, congenital generalized, type 1	0.011494299999999999	1.0344871034487102
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.011494299999999999	1.0344871034487102
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.011494299999999999	1.0344871034487102
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.011494299999999999	1.0344871034487102
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.011494299999999999	1.0344871034487102
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.011494299999999999	1.0344871034487102
FLOATING-HARBOR SYNDROME	0.011494299999999999	1.0344871034487102
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.011494299999999999	1.0344871034487102
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.011494299999999999	1.0344871034487102
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.011494299999999999	1.0344871034487102
#300867 KABUKI SYNDROME 2; KABUK2	0.011494299999999999	1.0344871034487102
JOUBERT SYNDROME 10	0.011494299999999999	1.0344871034487102
#158330 MULLERIAN APLASIA AND HYPERANDROGENISM;;MULLERIAN DUCT FAILURE AND HYPERANDROGENISM	0.011494299999999999	1.0344871034487102
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.011494299999999999	1.0344871034487102
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.011494299999999999	1.0344871034487102
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.011494299999999999	1.0344871034487102
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.011494299999999999	1.0344871034487102
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.011494299999999999	1.0344871034487102
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.011363600000000001	1.0227241022724103
CRANIOECTODERMAL DYSPLASIA 4	0.011363600000000001	1.0227241022724103
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.011363600000000001	1.0227241022724103
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.011363600000000001	1.0227241022724103
HALLERMANN-STREIFF SYNDROME; HSS	0.011363600000000001	1.0227241022724103
CARTILAGE-HAIR HYPOPLASIA; CHH	0.011363600000000001	1.0227241022724103
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.011363600000000001	1.0227241022724103
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.011363600000000001	1.0227241022724103
KOOLEN-DE VRIES SYNDROME; KDVS	0.011363600000000001	1.0227241022724103
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.011363600000000001	1.0227241022724103
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.011363600000000001	1.0227241022724103
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.011363600000000001	1.0227241022724103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.011363600000000001	1.0227241022724103
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.011363600000000001	1.0227241022724103
BAZEX SYNDROME; BZX	0.011363600000000001	1.0227241022724103
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.011363600000000001	1.0227241022724103
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.011363600000000001	1.0227241022724103
HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.011363600000000001	1.0227241022724103
MARFANOID HYPERMOBILITY SYNDROME	0.011363600000000001	1.0227241022724103
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.011363600000000001	1.0227241022724103
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.011363600000000001	1.0227241022724103
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.011363600000000001	1.0227241022724103
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.011363600000000001	1.0227241022724103
#608895 MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3	0.011363600000000001	1.0227241022724103
NEMALINE MYOPATHY 7; NEM7	0.011363600000000001	1.0227241022724103
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.011363600000000001	1.0227241022724103
ODONTOCHONDRODYSPLASIA; ODCD	0.011363600000000001	1.0227241022724103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.011363600000000001	1.0227241022724103
VESICOURETERAL REFLUX 8; VUR8	0.011363600000000001	1.0227241022724103
OSTEOGENESIS IMPERFECTA, TYPE I	0.011363600000000001	1.0227241022724103
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.011363600000000001	1.0227241022724103
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.011363600000000001	1.0227241022724103
WILSON DISEASE	0.011363600000000001	1.0227241022724103
MEIER-GORLIN SYNDROME 2; MGORS2	0.011363600000000001	1.0227241022724103
WARBURG MICRO SYNDROME 1	0.011363600000000001	1.0227241022724103
MACS SYNDROME	0.011363600000000001	1.0227241022724103
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.011363600000000001	1.0227241022724103
15q26 overgrowth syndrome	0.011363600000000001	1.0227241022724103
OSTEOGENESIS IMPERFECTA, TYPE V	0.011363600000000001	1.0227241022724103
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.01132297	1.0190674019067403
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.01132297	1.0190674019067403
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.01131034	1.0179307017930703
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.01131034	1.0179307017930703
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.01131034	1.0179307017930703
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.01131034	1.0179307017930703
MACROCEPHALY/AUTISM SYNDROME	0.01131034	1.0179307017930703
CHROMOSOME 2q37 DELETION SYNDROME	0.01131034	1.0179307017930703
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.01131034	1.0179307017930703
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.01131034	1.0179307017930703
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.0111037	0.9993330999333099
Xq28 (MECP2) duplication	0.0111037	0.9993330999333099
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0111037	0.9993330999333099
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0102621	0.9235890923589093
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0102621	0.9235890923589093
ATKIN-FLAITZ SYNDROME	0.0102621	0.9235890923589093
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.0102621	0.9235890923589093
CHOPS SYNDROME; CHOPS	0.0102621	0.9235890923589093
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.0102621	0.9235890923589093
Myhre syndrome	0.0102621	0.9235890923589093
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0102621	0.9235890923589093
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.010055459999999999	0.9049914904991488
AUTISM, SUSCEPTIBILITY TO, 18	0.010055459999999999	0.9049914904991488
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.010055459999999999	0.9049914904991488
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.010055459999999999	0.9049914904991488
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.010055459999999999	0.9049914904991488
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.010055459999999999	0.9049914904991488
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.010055459999999999	0.9049914904991488
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.010055459999999999	0.9049914904991488
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00966374	0.8697366869736687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.00966374	0.8697366869736687
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00966374	0.8697366869736687
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.00966374	0.8697366869736687
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00966374	0.8697366869736687
JOUBERT SYNDROME 35; JBTS35	0.00966374	0.8697366869736687
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00933193	0.8398737839873784
NOONAN SYNDROME 6; NS6	0.00933193	0.8398737839873784
COHEN-GIBSON SYNDROME; COGIS	0.00933193	0.8398737839873784
BRANCHIOOCULOFACIAL SYNDROME	0.00933193	0.8398737839873784
CHROMOSOME 9P DELETION SYNDROME	0.00933193	0.8398737839873784
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0086155	0.7753950775395078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.0086155	0.7753950775395078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.0086155	0.7753950775395078
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.0086155	0.7753950775395078
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0086155	0.7753950775395078
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0086155	0.7753950775395078
VERVERI-BRADY SYNDROME; VERBRAS	0.0086155	0.7753950775395078
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.0086155	0.7753950775395078
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0086155	0.7753950775395078
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0086155	0.7753950775395078
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0086155	0.7753950775395078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0086155	0.7753950775395078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0086155	0.7753950775395078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.0086155	0.7753950775395078
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.0086155	0.7753950775395078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.0086155	0.7753950775395078
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0086155	0.7753950775395078
GLYCEROL KINASE DEFICIENCY; GKD	0.0086155	0.7753950775395078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0086155	0.7753950775395078
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.0086155	0.7753950775395078
Bardet-Biedl syndrome 2	0.00840336	0.7563024756302477
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00840336	0.7563024756302477
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.00840336	0.7563024756302477
OBESITY-HYPOVENTILATION SYNDROME	0.00840336	0.7563024756302477
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00840336	0.7563024756302477
NARCOLEPSY 7; NRCLP7	0.00840336	0.7563024756302477
SENIOR-LOKEN SYNDROME 9	0.00840336	0.7563024756302477
#614662 CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2	0.00840336	0.7563024756302477
TRIGLYCERIDE STORAGE DISEASE, TYPE II	0.00840336	0.7563024756302477
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00840336	0.7563024756302477
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 13; BBS13	0.00840336	0.7563024756302477
HALOTHANE HEPATITIS	0.00840336	0.7563024756302477
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00840336	0.7563024756302477
JOUBERT SYNDROME 8	0.00840336	0.7563024756302477
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00840336	0.7563024756302477
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00840336	0.7563024756302477
SUMMITT SYNDROME	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 16; BBS16	0.00840336	0.7563024756302477
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.00840336	0.7563024756302477
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00840336	0.7563024756302477
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.00840336	0.7563024756302477
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 6; BBS6	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 12; BBS12	0.00840336	0.7563024756302477
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	0.00840336	0.7563024756302477
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 3; BBS3	0.00840336	0.7563024756302477
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00840336	0.7563024756302477
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00840336	0.7563024756302477
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00840336	0.7563024756302477
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.00840336	0.7563024756302477
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.00840336	0.7563024756302477
OBESITY	0.00840336	0.7563024756302477
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00840336	0.7563024756302477
Helsmoortel-van der Aa syndrome	0.00840336	0.7563024756302477
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.00840336	0.7563024756302477
SERTOLI CELL-ONLY SYNDROME	0.00840336	0.7563024756302477
LEPTIN DEFICIENCY OR DYSFUNCTION	0.00840336	0.7563024756302477
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 5; BBS5	0.00840336	0.7563024756302477
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.00840336	0.7563024756302477
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00840336	0.7563024756302477
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 17; BBS17	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 8; BBS8	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 4; BBS4	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 19; BBS19	0.00840336	0.7563024756302477
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 11; BBS11	0.00840336	0.7563024756302477
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00840336	0.7563024756302477
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00840336	0.7563024756302477
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.00840336	0.7563024756302477
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 9; BBS9	0.00840336	0.7563024756302477
RETINITIS PIGMENTOSA 71; RP71	0.00840336	0.7563024756302477
#615457 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18;;OBESITY, SUSCEPTIBILITY TO	0.00840336	0.7563024756302477
CLARK-BARAITSER SYNDROME	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 10; BBS10	0.00840336	0.7563024756302477
ULNAR-MAMMARY SYNDROME; UMS	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 14; BBS14	0.00840336	0.7563024756302477
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 7; BBS7	0.00840336	0.7563024756302477
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 18; BBS18	0.00840336	0.7563024756302477
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00840336	0.7563024756302477
248100 MACROSOMIA ADIPOSA CONGENITA	0.00840336	0.7563024756302477
BARDET-BIEDL SYNDROME 20	0.00840336	0.7563024756302477
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00819672	0.7377048737704873
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.00819672	0.7377048737704873
UROFACIAL SYNDROME 2	0.00819672	0.7377048737704873
AU-KLINE SYNDROME; AUKS	0.00819672	0.7377048737704873
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00819672	0.7377048737704873
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00819672	0.7377048737704873
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00819672	0.7377048737704873
Glycosylphosphatidylinositol biosynthesis defect 18	0.00819672	0.7377048737704873
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00819672	0.7377048737704873
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00819672	0.7377048737704873
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	0.7377048737704873
KAPUR-TORIELLO SYNDROME	0.00819672	0.7377048737704873
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	0.7377048737704873
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00819672	0.7377048737704873
NIEMANN-PICK DISEASE, TYPE A	0.00819672	0.7377048737704873
PROPIONIC ACIDEMIA	0.00819672	0.7377048737704873
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00819672	0.7377048737704873
HYPOPHOSPHATASIA, INFANTILE	0.00819672	0.7377048737704873
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00819672	0.7377048737704873
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00819672	0.7377048737704873
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00819672	0.7377048737704873
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00819672	0.7377048737704873
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00819672	0.7377048737704873
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00819672	0.7377048737704873
FG SYNDROME 2; FGS2	0.00819672	0.7377048737704873
RETT SYNDROME, CONGENITAL VARIANT	0.00819672	0.7377048737704873
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00819672	0.7377048737704873
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00819672	0.7377048737704873
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	0.7377048737704873
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.00819672	0.7377048737704873
611961 STEVENSON-CAREY SYNDROME	0.00819672	0.7377048737704873
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00819672	0.7377048737704873
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.00819672	0.7377048737704873
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00819672	0.7377048737704873
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00819672	0.7377048737704873
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00819672	0.7377048737704873
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00819672	0.7377048737704873
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00819672	0.7377048737704873
PARKINSON DISEASE, LATE-ONSET; PD	0.00819672	0.7377048737704873
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00819672	0.7377048737704873
RETT SYNDROME; RTT	0.00819672	0.7377048737704873
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00819672	0.7377048737704873
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	0.7377048737704873
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00819672	0.7377048737704873
MYXEDEMA	0.00819672	0.7377048737704873
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00819672	0.7377048737704873
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.00819672	0.7377048737704873
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00819672	0.7377048737704873
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00819672	0.7377048737704873
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00819672	0.7377048737704873
HOLOPROSENCEPHALY 2; HPE2	0.00819672	0.7377048737704873
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	0.7377048737704873
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00819672	0.7377048737704873
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00747319	0.6725871672587168
LAMB-SHAFFER SYNDROME	0.00747319	0.6725871672587168
#156550 KNIEST DYSPLASIA	0.00747319	0.6725871672587168
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00747319	0.6725871672587168
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.00747319	0.6725871672587168
EHLERS-DANLOS SYNDROME, TYPE VI	0.00747319	0.6725871672587168
VAN BOGAERT-HOZAY SYNDROME	0.00747319	0.6725871672587168
STICKLER SYNDROME, TYPE I	0.00747319	0.6725871672587168
COFFIN-SIRIS SYNDROME 1; CSS1	0.00747319	0.6725871672587168
#615665 JOUBERT SYNDROME 22; JBTS22	0.00675676	0.6081084608108461
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00675676	0.6081084608108461
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00675676	0.6081084608108461
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.00675676	0.6081084608108461
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00675676	0.6081084608108461
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00675676	0.6081084608108461
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.00675676	0.6081084608108461
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00675676	0.6081084608108461
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.00675676	0.6081084608108461
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00675676	0.6081084608108461
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00675676	0.6081084608108461
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00675676	0.6081084608108461
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00675676	0.6081084608108461
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00675676	0.6081084608108461
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00675676	0.6081084608108461
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00675676	0.6081084608108461
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.00675676	0.6081084608108461
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00675676	0.6081084608108461
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00675676	0.6081084608108461
MENTAL RETARDATION, X-LINKED 100	0.00675676	0.6081084608108461
NEPHROSIALIDOSIS	0.00675676	0.6081084608108461
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00675676	0.6081084608108461
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00675676	0.6081084608108461
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00675676	0.6081084608108461
MEGAEPIPHYSEAL DWARFISM	0.00675676	0.6081084608108461
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00675676	0.6081084608108461
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00675676	0.6081084608108461
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00675676	0.6081084608108461
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.00675676	0.6081084608108461
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00675676	0.6081084608108461
KLEEFSTRA SYNDROME 2; KLEFS2	0.00675676	0.6081084608108461
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.00675676	0.6081084608108461
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00675676	0.6081084608108461
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00675676	0.6081084608108461
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00675676	0.6081084608108461
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00675676	0.6081084608108461
CHROMOSOME 16p13.2 DELETION SYNDROME	0.00675676	0.6081084608108461
RODRIGUES BLINDNESS	0.00675676	0.6081084608108461
IMMUNODEFICIENCY 55; IMD55	0.00675676	0.6081084608108461
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00675676	0.6081084608108461
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00675676	0.6081084608108461
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00675676	0.6081084608108461
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00675676	0.6081084608108461
ZECHI-CEIDE SYNDROME	0.00675676	0.6081084608108461
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00675676	0.6081084608108461
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00675676	0.6081084608108461
IRIDOGONIODYSGENESIS, TYPE 2	0.00675676	0.6081084608108461
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00675676	0.6081084608108461
MENTAL RETARDATION, X-LINKED 102	0.00675676	0.6081084608108461
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00675676	0.6081084608108461
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.00675676	0.6081084608108461
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00675676	0.6081084608108461
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00675676	0.6081084608108461
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00675676	0.6081084608108461
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00675676	0.6081084608108461
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.00675676	0.6081084608108461
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00675676	0.6081084608108461
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.00675676	0.6081084608108461
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00675676	0.6081084608108461
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00675676	0.6081084608108461
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00675676	0.6081084608108461
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00675676	0.6081084608108461
KENNERKNECHT SYNDROME	0.00675676	0.6081084608108461
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.00675676	0.6081084608108461
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00675676	0.6081084608108461
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00675676	0.6081084608108461
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00675676	0.6081084608108461
601095 HARROD SYNDROME	0.00675676	0.6081084608108461
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00675676	0.6081084608108461
DIAMOND-BLACKFAN ANEMIA 4	0.00675676	0.6081084608108461
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00675676	0.6081084608108461
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00675676	0.6081084608108461
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00675676	0.6081084608108461
HAIRY ELBOWS	0.00675676	0.6081084608108461
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00675676	0.6081084608108461
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00675676	0.6081084608108461
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.00675676	0.6081084608108461
MENTAL RETARDATION, X-LINKED 14	0.00675676	0.6081084608108461
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00675676	0.6081084608108461
GASTROCUTANEOUS SYNDROME	0.0064249500000000005	0.5782455578245559
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.0064249500000000005	0.5782455578245559
CRI-DU-CHAT SYNDROME	0.0064249500000000005	0.5782455578245559
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0064249500000000005	0.5782455578245559
TEMTAMY SYNDROME; TEMTYS	0.0064249500000000005	0.5782455578245559
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.0064249500000000005	0.5782455578245559
HYPERTRYPTOPHANEMIA; HYPTRP	0.0064249500000000005	0.5782455578245559
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.0064249500000000005	0.5782455578245559
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0064249500000000005	0.5782455578245559
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0064249500000000005	0.5782455578245559
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0064249500000000005	0.5782455578245559
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.0064249500000000005	0.5782455578245559
PETERS-PLUS SYNDROME; PTRPLS	0.0064249500000000005	0.5782455578245559
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.00476572	0.42891484289148435
ZUNICH NEUROECTODERMAL SYNDROME	0.00476572	0.42891484289148435
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00476572	0.42891484289148435
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00476572	0.42891484289148435
CHROMOSOME 18Q DELETION SYNDROME	0.00476572	0.42891484289148435
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00476572	0.42891484289148435
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.00476572	0.42891484289148435
JACOBSEN SYNDROME	0.00476572	0.42891484289148435
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.00476572	0.42891484289148435
#150250 LARSEN SYNDROME; LRS	0.00476572	0.42891484289148435
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00476572	0.42891484289148435
DIAPHANOSPONDYLODYSOSTOSIS	0.00476572	0.42891484289148435
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.00476572	0.42891484289148435
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00476572	0.42891484289148435
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00476572	0.42891484289148435
#609597 PARIETAL FORAMINA 2; PFM2	0.00476572	0.42891484289148435
WEAVER SYNDROME	0.00476572	0.42891484289148435
CAMPOMELIC DYSPLASIA	0.00476572	0.42891484289148435
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00476572	0.42891484289148435
RING CHROMOSOME 14 SYNDROME	0.00476572	0.42891484289148435
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.00476572	0.42891484289148435
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.00476572	0.42891484289148435
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00476572	0.42891484289148435
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.00476572	0.42891484289148435
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00476572	0.42891484289148435
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00476572	0.42891484289148435
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00476572	0.42891484289148435
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00476572	0.42891484289148435
311450 PALLISTER W SYNDROME;;W SYNDROME	0.00476572	0.42891484289148435
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.00476572	0.42891484289148435
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00476572	0.42891484289148435
#611554 LEOPARD SYNDROME 2	0.00476572	0.42891484289148435
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00476572	0.42891484289148435
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00476572	0.42891484289148435
RAINE SYNDROME	0.00476572	0.42891484289148435
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00476572	0.42891484289148435
NOONAN SYNDROME 4; NS4	0.00476572	0.42891484289148435
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00476572	0.42891484289148435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00476572	0.42891484289148435
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00476572	0.42891484289148435
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.00476572	0.42891484289148435
CLEIDOCRANIAL DYSPLASIA; CCD	0.00476572	0.42891484289148435
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00476572	0.42891484289148435
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00476572	0.42891484289148435
FRONTONASAL DYSPLASIA 2; FND2	0.00476572	0.42891484289148435
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00476572	0.42891484289148435
ADAMS-OLIVER SYNDROME 2; AOS2	0.00476572	0.42891484289148435
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.00476572	0.42891484289148435
FUMARASE DEFICIENCY; FMRD	0.00476572	0.42891484289148435
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00476572	0.42891484289148435
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00476572	0.42891484289148435
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00476572	0.42891484289148435
CHITAYAT SYNDROME	0.00476572	0.42891484289148435
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00476572	0.42891484289148435
SMITH-KINGSMORE SYNDROME; SKS	0.00476572	0.42891484289148435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00476572	0.42891484289148435
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00476572	0.42891484289148435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00476572	0.42891484289148435
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00476572	0.42891484289148435
OPSISMODYSPLASIA; OPSMD	0.00476572	0.42891484289148435
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00476572	0.42891484289148435
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00476572	0.42891484289148435
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00476572	0.42891484289148435
PELGER-HUET ANOMALY; PHA	0.00476572	0.42891484289148435
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.00476572	0.42891484289148435
NASODIGITOACOUSTIC SYNDROME	0.00476572	0.42891484289148435
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00476572	0.42891484289148435
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00476572	0.42891484289148435
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00476572	0.42891484289148435
AYME-GRIPP SYNDROME; AYGRP	0.00476572	0.42891484289148435
#613707 LEOPARD SYNDROME 3; LPRD3	0.00476572	0.42891484289148435
HYPERTELORISM, TEEBI TYPE; TBHS	0.00476572	0.42891484289148435
NOONAN SYNDROME 11; NS11	0.00476572	0.42891484289148435
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00476572	0.42891484289148435
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00476572	0.42891484289148435
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.00476572	0.42891484289148435
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00476572	0.42891484289148435
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00476572	0.42891484289148435
JOUBERT SYNDROME 32; JBTS32	0.00476572	0.42891484289148435
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00476572	0.42891484289148435
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00476572	0.42891484289148435
HEART AND BRAIN MALFORMATION SYNDROME	0.00476572	0.42891484289148435
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00476572	0.42891484289148435
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00476572	0.42891484289148435
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00476572	0.42891484289148435
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00476572	0.42891484289148435
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00476572	0.42891484289148435
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00476572	0.42891484289148435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00476572	0.42891484289148435
RITSCHER-SCHINZEL SYNDROME 1	0.00476572	0.42891484289148435
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.00476572	0.42891484289148435
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.00476572	0.42891484289148435
CHROMOSOME 16Q22 DELETION SYNDROME	0.00476572	0.42891484289148435
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00476572	0.42891484289148435
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.00476572	0.42891484289148435
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00476572	0.42891484289148435
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00476572	0.42891484289148435
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00476572	0.42891484289148435
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00456621	0.41095894109589415
OPTIC ATROPHY 11; OPA11	0.00456621	0.41095894109589415
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00456621	0.41095894109589415
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00456621	0.41095894109589415
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00456621	0.41095894109589415
GLAUCOMA 1, OPEN ANGLE, A	0.00456621	0.41095894109589415
%609257 MYOPIA 8; MYP8	0.00456621	0.41095894109589415
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00456621	0.41095894109589415
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.00456621	0.41095894109589415
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00456621	0.41095894109589415
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00456621	0.41095894109589415
MUCOLIPIDOSIS III GAMMA	0.00456621	0.41095894109589415
#614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;NPHS5	0.00456621	0.41095894109589415
MARFANOID HABITUS WITH SITUS INVERSUS	0.00456621	0.41095894109589415
RETINITIS PIGMENTOSA 1	0.00456621	0.41095894109589415
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00456621	0.41095894109589415
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00456621	0.41095894109589415
MYOPIA, INFANTILE SEVERE	0.00456621	0.41095894109589415
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00456621	0.41095894109589415
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00456621	0.41095894109589415
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00456621	0.41095894109589415
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00456621	0.41095894109589415
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00456621	0.41095894109589415
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00456621	0.41095894109589415
COWDEN SYNDROME 6; CWS6	0.00456621	0.41095894109589415
GLAUCOMA, PRIMARY OPEN ANGLE	0.00456621	0.41095894109589415
#615058 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F	0.00456621	0.41095894109589415
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00456621	0.41095894109589415
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00456621	0.41095894109589415
FRONTOOCULAR SYNDROME	0.00456621	0.41095894109589415
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00456621	0.41095894109589415
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00456621	0.41095894109589415
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00456621	0.41095894109589415
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00456621	0.41095894109589415
HUNTER-MACDONALD SYNDROME	0.00456621	0.41095894109589415
#310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A;;CSNB, COMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, WITH MYOPIA;;HEMERALOPIA-MYOPIA;;MYOPIA-NIGHT BLINDNESS; NBM1NYCTALOPIA, INCLUDED	0.00456621	0.41095894109589415
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00456621	0.41095894109589415
#312600 RETINITIS PIGMENTOSA 2; RP2	0.00456621	0.41095894109589415
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00456621	0.41095894109589415
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00456621	0.41095894109589415
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00456621	0.41095894109589415
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00456621	0.41095894109589415
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.00456621	0.41095894109589415
COWDEN SYNDROME 5; CWS5	0.00456621	0.41095894109589415
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00456621	0.41095894109589415
SVEINSSON CHORIORETINAL ATROPHY	0.00456621	0.41095894109589415
ALPORT SYNDROME, X-LINKED; ATS	0.00456621	0.41095894109589415
SHORT SYNDROME	0.00456621	0.41095894109589415
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00456621	0.41095894109589415
%609258 MYOPIA 9; MYP9	0.00456621	0.41095894109589415
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00456621	0.41095894109589415
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00456621	0.41095894109589415
WEILL-MARCHESANI SYNDROME 3	0.00456621	0.41095894109589415
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00456621	0.41095894109589415
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00456621	0.41095894109589415
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.00456621	0.41095894109589415
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00456621	0.41095894109589415
#608908 MYOPIA 6; MYP6	0.00456621	0.41095894109589415
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00456621	0.41095894109589415
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.00456621	0.41095894109589415
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00456621	0.41095894109589415
#257270 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B;;NIGHT BLINDNESS, CONGENITAL STATIONARY, COMPLETE, AUTOSOMAL RECESSIVE;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00456621	0.41095894109589415
MICROSPHEROPHAKIA WITH HERNIA	0.00456621	0.41095894109589415
SENGERS SYNDROME	0.00456621	0.41095894109589415
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00456621	0.41095894109589415
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00456621	0.41095894109589415
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00456621	0.41095894109589415
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00456621	0.41095894109589415
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00456621	0.41095894109589415
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00456621	0.41095894109589415
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00456621	0.41095894109589415
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00456621	0.41095894109589415
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00456621	0.41095894109589415
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.00456621	0.41095894109589415
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00456621	0.41095894109589415
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00456621	0.41095894109589415
#609508 STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR;;STICKLER SYNDROME, TYPE I, PREDOMINANTLY OCULAR;;STICKLER SYNDROME, ATYPICALRHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT, INCLUDED; DRRD,INCLUDED	0.00456621	0.41095894109589415
ALAND ISLAND EYE DISEASE	0.00456621	0.41095894109589415
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00456621	0.41095894109589415
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00456621	0.41095894109589415
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.00456621	0.41095894109589415
#115900 CATARACT 42; CTRCT42	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00456621	0.41095894109589415
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00456621	0.41095894109589415
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.00456621	0.41095894109589415
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00456621	0.41095894109589415
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00456621	0.41095894109589415
%609256 MYOPIA 7; MYP7	0.00456621	0.41095894109589415
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00456621	0.41095894109589415
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.00456621	0.41095894109589415
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00456621	0.41095894109589415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00456621	0.41095894109589415
BLUE CONE MONOCHROMACY; BCM	0.00456621	0.41095894109589415
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00456621	0.41095894109589415
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00456621	0.41095894109589415
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00456621	0.41095894109589415
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00456621	0.41095894109589415
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00456621	0.41095894109589415
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.00456621	0.41095894109589415
RETINITIS PIGMENTOSA 75; RP75	0.00456621	0.41095894109589415
BRITTLE CORNEA SYNDROME	0.00456621	0.41095894109589415
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00456621	0.41095894109589415
#615420 MYOPIA 22, AUTOSOMAL DOMINANT; MYP22	0.00456621	0.41095894109589415
%609259 MYOPIA 10; MYP10	0.00456621	0.41095894109589415
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00456621	0.41095894109589415
MICROCORIA, CONGENITAL	0.00456621	0.41095894109589415
%310460 MYOPIA 1, X-LINKED; MYP1	0.00456621	0.41095894109589415
EHLERS-DANLOS SYNDROME, TYPE I	0.00456621	0.41095894109589415
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00456621	0.41095894109589415
FLYNN-AIRD SYNDROME	0.00456621	0.41095894109589415
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00456621	0.41095894109589415
MYOPIA 15; MYP15	0.00456621	0.41095894109589415
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00456621	0.41095894109589415
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00456621	0.41095894109589415
CRANIOECTODERMAL DYSPLASIA 1	0.00456621	0.41095894109589415
RETINAL CONE DYSTROPHY 3B	0.00456621	0.41095894109589415
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00456621	0.41095894109589415
MEIER-GORLIN SYNDROME 7	0.00456621	0.41095894109589415
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.00290698	0.2616282261628226
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.00290698	0.2616282261628226
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00290698	0.2616282261628226
THREE M SYNDROME 2; 3M2	0.00290698	0.2616282261628226
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00290698	0.2616282261628226
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00290698	0.2616282261628226
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00290698	0.2616282261628226
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.00290698	0.2616282261628226
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00290698	0.2616282261628226
KYPHOMELIC DYSPLASIA	0.00290698	0.2616282261628226
#100800 ACHONDROPLASIA; ACH	0.00290698	0.2616282261628226
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00290698	0.2616282261628226
CALVARIAL HYPEROSTOSIS	0.00290698	0.2616282261628226
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00290698	0.2616282261628226
#200600 ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE	0.00290698	0.2616282261628226
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00290698	0.2616282261628226
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00290698	0.2616282261628226
OCULOECTODERMAL SYNDROME; OES	0.00290698	0.2616282261628226
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00290698	0.2616282261628226
OMODYSPLASIA 1; OMOD1	0.00290698	0.2616282261628226
CODAS SYNDROME	0.00290698	0.2616282261628226
COFFIN-SIRIS SYNDROME 5	0.00290698	0.2616282261628226
268650 RUDIGER SYNDROME	0.00290698	0.2616282261628226
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00290698	0.2616282261628226
KEUTEL SYNDROME; KTLS	0.00290698	0.2616282261628226
HYPOTONIA-CYSTINURIA SYNDROME	0.00290698	0.2616282261628226
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00290698	0.2616282261628226
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00290698	0.2616282261628226
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00290698	0.2616282261628226
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.00290698	0.2616282261628226
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00290698	0.2616282261628226
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00290698	0.2616282261628226
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00290698	0.2616282261628226
MENTAL RETARDATION, X-LINKED 9	0.00290698	0.2616282261628226
GLUTAMINE DEFICIENCY, CONGENITAL	0.00290698	0.2616282261628226
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00290698	0.2616282261628226
OMODYSPLASIA	0.00290698	0.2616282261628226
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.00290698	0.2616282261628226
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00290698	0.2616282261628226
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.00290698	0.2616282261628226
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.00290698	0.2616282261628226
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00290698	0.2616282261628226
SCHEIE SYNDROME	0.00290698	0.2616282261628226
FIBROCHONDROGENESIS 1; FBCG1	0.00290698	0.2616282261628226
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00290698	0.2616282261628226
POPOV-CHANG SYNDROME; POPCHAS	0.00290698	0.2616282261628226
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00290698	0.2616282261628226
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.00290698	0.2616282261628226
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00290698	0.2616282261628226
OGDEN SYNDROME; OGDNS	0.00290698	0.2616282261628226
TIMOTHY SYNDROME; TS	0.00290698	0.2616282261628226
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00290698	0.2616282261628226
OHDO SYNDROME	0.00290698	0.2616282261628226
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00290698	0.2616282261628226
SONODA SYNDROME	0.00290698	0.2616282261628226
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00290698	0.2616282261628226
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00290698	0.2616282261628226
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00290698	0.2616282261628226
COFFIN-SIRIS SYNDROME 2; CSS2	0.00290698	0.2616282261628226
FACIAL ECTODERMAL DYSPLASIA	0.00290698	0.2616282261628226
CHROMOSOME 17q12 DELETION SYNDROME	0.00290698	0.2616282261628226
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00290698	0.2616282261628226
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00290698	0.2616282261628226
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00290698	0.2616282261628226
OROFACIODIGITAL SYNDROME X	0.00290698	0.2616282261628226
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00290698	0.2616282261628226
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00290698	0.2616282261628226
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00290698	0.2616282261628226
PROTEUS SYNDROME	0.00290698	0.2616282261628226
Congenital disorder of glycosylation, type IIh	0.00290698	0.2616282261628226
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00290698	0.2616282261628226
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00290698	0.2616282261628226
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.00290698	0.2616282261628226
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00290698	0.2616282261628226
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00290698	0.2616282261628226
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.00290698	0.2616282261628226
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00290698	0.2616282261628226
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00290698	0.2616282261628226
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00290698	0.2616282261628226
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00290698	0.2616282261628226
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00290698	0.2616282261628226
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.00290698	0.2616282261628226
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00290698	0.2616282261628226
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.00290698	0.2616282261628226
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00290698	0.2616282261628226
ASPARTYLGLUCOSAMINURIA; AGU	0.00290698	0.2616282261628226
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00290698	0.2616282261628226
ALAZAMI SYNDROME; ALAZS	0.00290698	0.2616282261628226
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00290698	0.2616282261628226
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00290698	0.2616282261628226
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00290698	0.2616282261628226
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.00290698	0.2616282261628226
FACIOCARDIOMELIC SYNDROME	0.00290698	0.2616282261628226
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00290698	0.2616282261628226
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00290698	0.2616282261628226
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00290698	0.2616282261628226
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00290698	0.2616282261628226
HOLOPROSENCEPHALY 4	0.00290698	0.2616282261628226
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.00290698	0.2616282261628226
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00290698	0.2616282261628226
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00290698	0.2616282261628226
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.00290698	0.2616282261628226
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00290698	0.2616282261628226
HOLOPROSENCEPHALY 3; HPE3	0.00290698	0.2616282261628226
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00290698	0.2616282261628226
PALLISTER-HALL SYNDROME	0.00290698	0.2616282261628226
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00290698	0.2616282261628226
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00290698	0.2616282261628226
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00290698	0.2616282261628226
MEIER-GORLIN SYNDROME 6; MGORS6	0.00290698	0.2616282261628226
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00290698	0.2616282261628226
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00290698	0.2616282261628226
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00290698	0.2616282261628226
MARTSOLF SYNDROME	0.00290698	0.2616282261628226
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.00290698	0.2616282261628226
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.00290698	0.2616282261628226
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.00185874	0.16728661672866166
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00185874	0.16728661672866166
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00185874	0.16728661672866166
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00185874	0.16728661672866166
OROFACIODIGITAL SYNDROME V; OFD5	0.00185874	0.16728661672866166
VICI SYNDROME; VICIS	0.00185874	0.16728661672866166
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00185874	0.16728661672866166
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00185874	0.16728661672866166
JOUBERT SYNDROME 14	0.00185874	0.16728661672866166
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00185874	0.16728661672866166
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00185874	0.16728661672866166
HAMAMY SYNDROME; HMMS	0.00185874	0.16728661672866166
STROMME SYNDROME; STROMS	0.00185874	0.16728661672866166
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00185874	0.16728661672866166
ROBINOW-SORAUF SYNDROME	0.00185874	0.16728661672866166
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.00185874	0.16728661672866166
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00185874	0.16728661672866166
ARTERIAL TORTUOSITY SYNDROME	0.00185874	0.16728661672866166
STEEL SYNDROME; STLS	0.00185874	0.16728661672866166
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00185874	0.16728661672866166
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00185874	0.16728661672866166
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00185874	0.16728661672866166
3MC SYNDROME 1	0.00185874	0.16728661672866166
3MC SYNDROME 3	0.00185874	0.16728661672866166
LAMBOTTE SYNDROME	0.00185874	0.16728661672866166
MESOMELIA-SYNOSTOSES SYNDROME	0.00185874	0.16728661672866166
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00185874	0.16728661672866166
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00185874	0.16728661672866166
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00185874	0.16728661672866166
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00185874	0.16728661672866166
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00185874	0.16728661672866166
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00185874	0.16728661672866166
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00185874	0.16728661672866166
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00185874	0.16728661672866166
NOONAN SYNDROME 3; NS3	0.00185874	0.16728661672866166
CREE MENTAL RETARDATION SYNDROME	0.00185874	0.16728661672866166
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00185874	0.16728661672866166
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00185874	0.16728661672866166
OROFACIAL CLEFT 15	0.00185874	0.16728661672866166
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.00185874	0.16728661672866166
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00185874	0.16728661672866166
LARSEN-LIKE SYNDROME	0.00185874	0.16728661672866166
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00185874	0.16728661672866166
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00185874	0.16728661672866166
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00185874	0.16728661672866166
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00185874	0.16728661672866166
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00185874	0.16728661672866166
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00185874	0.16728661672866166
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00185874	0.16728661672866166
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00185874	0.16728661672866166
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00185874	0.16728661672866166
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00185874	0.16728661672866166
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00185874	0.16728661672866166
TRICHOHEPATOENTERIC SYNDROME 1	0.00185874	0.16728661672866166
CHROMOSOME 4q21 DELETION SYNDROME	0.00185874	0.16728661672866166
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.00185874	0.16728661672866166
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.00185874	0.16728661672866166
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00185874	0.16728661672866166
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00185874	0.16728661672866166
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00185874	0.16728661672866166
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00185874	0.16728661672866166
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00185874	0.16728661672866166
SWEENEY-COX SYNDROME; SWCOS	0.00185874	0.16728661672866166
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00185874	0.16728661672866166
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.00185874	0.16728661672866166
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00185874	0.16728661672866166
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00185874	0.16728661672866166
SCHIZOPHRENIA 1; SCZD1	0.00185874	0.16728661672866166
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00185874	0.16728661672866166
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.00185874	0.16728661672866166
FRYNS SYNDROME; FRNS	0.00185874	0.16728661672866166
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00185874	0.16728661672866166
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00185874	0.16728661672866166
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00185874	0.16728661672866166
CHROMOSOME 1p35 DELETION SYNDROME	0.00185874	0.16728661672866166
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00185874	0.16728661672866166
FRIAS SYNDROME	0.00185874	0.16728661672866166
ROBERTS SYNDROME; RBS	0.00185874	0.16728661672866166
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.00185874	0.16728661672866166
CRANIOSYNOSTOSIS 6; CRS6	0.00185874	0.16728661672866166
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.00185874	0.16728661672866166
OROFACIODIGITAL SYNDROME I; OFD1	0.00185874	0.16728661672866166
CRANIOFRONTONASAL SYNDROME; CFNS	0.00185874	0.16728661672866166
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00185874	0.16728661672866166
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00185874	0.16728661672866166
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00185874	0.16728661672866166
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.00185874	0.16728661672866166
OROFACIODIGITAL SYNDROME IX; OFD9	0.00185874	0.16728661672866166
Pierpont syndrome	0.00185874	0.16728661672866166
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.00185874	0.16728661672866166
WHITE FORELOCK WITH MALFORMATIONS	0.00185874	0.16728661672866166
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.00185874	0.16728661672866166
CEREBROOCULONASAL SYNDROME	0.00185874	0.16728661672866166
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00185874	0.16728661672866166
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00185874	0.16728661672866166
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00185874	0.16728661672866166
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00185874	0.16728661672866166
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00185874	0.16728661672866166
MECKEL SYNDROME, TYPE 1; MKS1	0.00185874	0.16728661672866166
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.00185874	0.16728661672866166
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00185874	0.16728661672866166
ABLEPHARON-MACROSTOMIA SYNDROME	0.00185874	0.16728661672866166
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.00185874	0.16728661672866166
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00185874	0.16728661672866166
BARTSOCAS-PAPAS SYNDROME; BPS	0.00185874	0.16728661672866166
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00185874	0.16728661672866166
CROUZON SYNDROME	0.00185874	0.16728661672866166
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00185874	0.16728661672866166
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00185874	0.16728661672866166
POTOCKI-LUPSKI SYNDROME	0.00185874	0.16728661672866166
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00185874	0.16728661672866166
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.00185874	0.16728661672866166
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00185874	0.16728661672866166
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00185874	0.16728661672866166
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00185874	0.16728661672866166
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00185874	0.16728661672866166
LOEYS-DIETZ SYNDROME 3; LDS3	0.00185874	0.16728661672866166
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00185874	0.16728661672866166
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00185874	0.16728661672866166
TRICHOHEPATOENTERIC SYNDROME 2	0.00185874	0.16728661672866166
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00185874	0.16728661672866166
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00185874	0.16728661672866166
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00185874	0.16728661672866166
DIAMOND-BLACKFAN ANEMIA 5	0.00185874	0.16728661672866166
DIAMOND-BLACKFAN ANEMIA 8	0.00185874	0.16728661672866166
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00185874	0.16728661672866166
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00185874	0.16728661672866166
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00185874	0.16728661672866166
KBG SYNDROME	0.00185874	0.16728661672866166
COFFIN-LOWRY SYNDROME; CLS	0.00185874	0.16728661672866166
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.00185874	0.16728661672866166
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.00185874	0.16728661672866166
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00185874	0.16728661672866166
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00185874	0.16728661672866166
BASAL CELL NEVUS SYNDROME	0.00185874	0.16728661672866166
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00185874	0.16728661672866166
NOONAN SYNDROME 8; NS8	0.00185874	0.16728661672866166
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00185874	0.16728661672866166
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.00185874	0.16728661672866166
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00185874	0.16728661672866166
#256520 NEU-LAXOVA SYNDROME; NLS	0.00185874	0.16728661672866166
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00185874	0.16728661672866166
CRANIOSYNOSTOSIS 4; CRS4	0.00185874	0.16728661672866166
NF1-microdeletion syndrome	0.00185874	0.16728661672866166
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00185874	0.16728661672866166
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.00185874	0.16728661672866166
HARTSFIELD SYNDROME; HRTFDS	0.00185874	0.16728661672866166
WIDOW'S PEAK	0.00185874	0.16728661672866166
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00185874	0.16728661672866166
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00185874	0.16728661672866166
COACH SYNDROME	0.00185874	0.16728661672866166
TARP SYNDROME; TARPS	0.00185874	0.16728661672866166
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00185874	0.16728661672866166
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00185874	0.16728661672866166
OROFACIODIGITAL SYNDROME XV; OFD15	0.00185874	0.16728661672866166
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00185874	0.16728661672866166
DUANE-RADIAL RAY SYNDROME; DRRS	0.00185874	0.16728661672866166
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00185874	0.16728661672866166
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00185874	0.16728661672866166
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00185874	0.16728661672866166
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00185874	0.16728661672866166
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00185874	0.16728661672866166
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00185874	0.16728661672866166
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00185874	0.16728661672866166
SCLEROSTEOSIS 2; SOST2	0.00185874	0.16728661672866166
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00185874	0.16728661672866166
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00185874	0.16728661672866166
FRANK-TER HAAR SYNDROME; FTHS	0.00185874	0.16728661672866166
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00185874	0.16728661672866166
SIFRIM-HITZ-WEISS SYNDROME	0.00185874	0.16728661672866166
TEEBI-SHALTOUT SYNDROME; TBSH	0.00185874	0.16728661672866166
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00185874	0.16728661672866166
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00185874	0.16728661672866166
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00185874	0.16728661672866166
JOUBERT SYNDROME 26	0.00185874	0.16728661672866166
MARDEN-WALKER SYNDROME	0.00185874	0.16728661672866166
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00185874	0.16728661672866166
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00185874	0.16728661672866166
NOONAN SYNDROME 2; NS2	0.00185874	0.16728661672866166
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00185874	0.16728661672866166
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00185874	0.16728661672866166
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00185874	0.16728661672866166
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.00185874	0.16728661672866166
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00185874	0.16728661672866166
MANITOBA OCULOTRICHOANAL SYNDROME	0.00185874	0.16728661672866166
CHARGE SYNDROME	0.00185874	0.16728661672866166
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00185874	0.16728661672866166
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.00185874	0.16728661672866166
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00185874	0.16728661672866166
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00185874	0.16728661672866166
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00185874	0.16728661672866166
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00185874	0.16728661672866166
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.00185874	0.16728661672866166
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.00185874	0.16728661672866166
SHASHI-PENA SYNDROME; SHAPNS	0.00185874	0.16728661672866166
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00185874	0.16728661672866166
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00185874	0.16728661672866166
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00185874	0.16728661672866166
600736 VELOFACIOSKELETAL SYNDROME	0.00185874	0.16728661672866166
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00185874	0.16728661672866166
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00185874	0.16728661672866166
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00185874	0.16728661672866166
MELNICK-NEEDLES SYNDROME	0.00185874	0.16728661672866166
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00185874	0.16728661672866166
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00185874	0.16728661672866166
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00185874	0.16728661672866166
CHROMOSOME 18P DELETION SYNDROME	0.00185874	0.16728661672866166
KEIPERT SYNDROME; KPTS	0.00185874	0.16728661672866166
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00185874	0.16728661672866166
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00185874	0.16728661672866166
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00185874	0.16728661672866166
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.00185874	0.16728661672866166
NEMALINE MYOPATHY 2; NEM2	0.00185874	0.16728661672866166
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.00185874	0.16728661672866166
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00185874	0.16728661672866166
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00185874	0.16728661672866166
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00185874	0.16728661672866166
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00185874	0.16728661672866166
ACROCALLOSAL SYNDROME; ACLS	0.00185874	0.16728661672866166
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00185874	0.16728661672866166
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.00185874	0.16728661672866166
%608572 BURN-MCKEOWN SYNDROME	0.00185874	0.16728661672866166
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00185874	0.16728661672866166
NOONAN SYNDROME 10; NS10	0.00185874	0.16728661672866166
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00185874	0.16728661672866166
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00185874	0.16728661672866166
NEU-LAXOVA SYNDROME 2; NLS2	0.00185874	0.16728661672866166
FRONTONASAL DYSPLASIA 1; FND1	0.00185874	0.16728661672866166
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00185874	0.16728661672866166
Mental retardation, autosomal dominant 21	0.00185874	0.16728661672866166
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00185874	0.16728661672866166
OROFACIODIGITAL SYNDROME III	0.00185874	0.16728661672866166
BARBER-SAY SYNDROME; BBRSAY	0.00185874	0.16728661672866166
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00185874	0.16728661672866166
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.00185874	0.16728661672866166
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.00185874	0.16728661672866166
CHAR SYNDROME	0.00185874	0.16728661672866166
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00185874	0.16728661672866166
OROFACIODIGITAL SYNDROME IV; OFD4	0.00185874	0.16728661672866166
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00185874	0.16728661672866166
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00185874	0.16728661672866166
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00185874	0.16728661672866166
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00185874	0.16728661672866166
NOONAN SYNDROME 9; NS9	0.00185874	0.16728661672866166
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00185874	0.16728661672866166
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.00185874	0.16728661672866166
HYPERTELORISM	0.00185874	0.16728661672866166
